Discovery & Development

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Immunotherapies can accomplish much, but we can only unlock their true power through collaboration.

How next-generation drug delivery and advanced automation are set to transform pharma’s future.

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

How to meet the demand for first-in-human clinical trials using fit-for-phase formulation approaches.

How a collaboration between different organizations aims to advance perfusion for cell and gene therapies.

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

Milton Boyer and Dave Stevens delve into the company’s evolution and expertise in sterile manufacturing and drug delivery systems.

How immunotherapy could redefine cancer treatment.